Investor insights
Sectors invested in
Biotechnology5
Health Care4
Therapeutics3
Health Diagnostics3
antimicrobial peptides2
Infectious Disease2
Drug Development2
Bacteriophage2
Targeted Antimicrobials2
Microbiome2
Phage2
Clinical-Stage2
Engineered Phage2
targeted phage-based drugs2
Synthetic Biology2
Inhalation therapy1
Drug Formulation1
Regulatory Affairs1
Cardiovascular1
Commercialization1
Funding rounds participated in
$30M sweet spot round size
Most of their 5 investments are in rounds between $2.2M and $30M
Investor type
Venture Capital
Basic info
Industry
financial services
Sectors
Biotechnology
Financial Services
Pharmaceutical
Date founded
1996
Investments made
A
Armata Pharmaceuticals, Inc. raised $30M on January 10, 2023
Investors: Innoviva
G
Gate Neurosciences, Inc. raised $25M on October 5, 2022
Investors: Thornapple River Capital, BioCrossroads and Innoviva
N
Nanolive SA raised $2.2M on September 20, 2022
Investors: Taiwania Capital and Innoviva
A
Armata Pharmaceuticals, Inc. raised $45M on February 9, 2022
Investors: Innoviva
I
InCarda Therapeutics raised $30M on October 21, 2020
Investors: HealthCap, Morningside Venture Capital 晨兴资本 and Innoviva